SELECT FROM MENU

Therapy Areas
Drug Classes

       Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Advanced NSCLC

Advanced NSCLC

SCLC

SCLC

Biomarkers

Biomarkers

       Drug Classes

Targeted Therapies

Targeted Therapies

Immunotherapies

Immunotherapies

ADCs

ADCs

Andrea Filippi

Andrea Filippi

Istituto Nazionale dei Tumori, Milan

Prof. Andrea Riccardo Filippi heads the Radiation Oncology Unit at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan and is Associate Professor of Radiotherapy in the Department of Oncology at the University of Milan. His thoracic work centers on stereotactic body radiotherapy and the integration of radiotherapy with immunotherapy in non-small cell lung cancer, including consolidation durvalumab after chemoradiation in stage III disease. He contributes to international guidance through ESTRO, IASLC, and ESMO, including the IASLC Advanced Radiation Technology Subcommittee and an ESTRO clinical practice guideline on radiation-induced pneumonitis. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Andrea Filippi

Featured in